Equinix enters September with an odd split personality: the stock is down 4.3% on the week to $1,027.59, yet nearly every positioning metric is moving in the bulls' favour.
The short side has continued to deflate since last week's note. Short interest has fallen a further 14% over the past week to 1.66% of the free float — its lowest reading in months and a level that simply doesn't register as meaningful pressure. Bears covered aggressively: from roughly 1.9 million shares short in mid-August, the position has compressed to around 1.6 million. The borrow market reflects the same disinterest — availability is extraordinarily loose, with over 84 million shares available against the roughly 1.6 million borrowed. Cost to borrow, at 0.31%, is the cheapest it has been in the past month. The ORTEX short score has tracked this drift lower, settling at 31.2 on September 1 after spending most of August in the low-to-mid 32s. Positioning looks wholly unburdened by short pressure.
Options tell a different story, though not one of outright fear. The put/call ratio eased to 2.30 on Tuesday, notably more bullish than the 20-day average of 2.69 and about 1.5 standard deviations below that mean. That's the most call-heavy reading in several weeks — a sharp reversal from late July, when the PCR briefly touched 3.55, the highest level of the past year. The directional drift in options over August has been steadily toward calls, even as the stock has sold off. For a high-priced REIT where investors routinely use puts as rate-sensitivity hedges, that tightening put/call is worth noting.
The Street remains constructively positioned. Evercore ISI lifted its target to $1,270 on August 18, the most recent analyst action on file. Earlier in the month RBC raised its target to $1,225 from $1,125, and the broad cluster of post-earnings moves in late July — UBS to $1,265, Stifel to $1,265, TD Cowen to $1,166 — all maintained Buy-equivalent ratings. Only Barclays sits at Equal-Weight, with a $1,130 target. The consensus mean of roughly $1,235 implies about 20% upside from current levels, a gap that has widened as the stock has pulled back. Factor scores back the bull case on several dimensions: the dividend score ranks in the 88th percentile of the universe, days-to-cover in the 82nd, and short score rank in the 71st. EPS momentum over the near term (68th percentile on the 30-day reading) is healthy, though the 90-day read at the 39th percentile is more pedestrian. Valuation is where the bears find traction — at roughly 58x trailing earnings and an EV/EBITDA near 22x, Equinix prices in a lot of AI-demand optionality.
The one genuine red flag is an insider sale. Director Christopher Paisley sold 4,000 shares on August 3 at $1,019.28, a $4.1 million discretionary sale with no 10b5-1 plan attached. Discretionary director sales are worth flagging, though a single board-member trade lacks the weight of an executive cluster. The only executive trades in the window are CFO Keith Taylor's January sales, all executed under a pre-arranged 10b5-1 plan — routine compensation mechanics rather than conviction signals.
Close peer DLR fell 4.7% on the week, broadly in line with EQIX, confirming this is sector-wide weakness rather than a company-specific story. IRM dropped 5.5%, while the data center REIT cohort appears to be repricing against the backdrop of rate sensitivity — the same headwind Equinix faces structurally as a REIT with significant leverage. Q3 earnings land October 28, and with analyst targets running 20% above current levels, that print will be the next real test of whether the AI-demand narrative continues to justify the premium multiple.
See the live data behind this article on ORTEX.
Open EQIX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
